The immunologically sensitised renal transplant recipient: the impact of advances in technology on organ allocation and transplant outcome

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Transplantation Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0955-470X(99)80006-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A positive B cell crossmatch due to IgG anti-HLA-DQ antibody present at the time of transplantation in a successful renal allograft.

  2008cited by this paper
• Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodies.

  2008cited by this paper
• A novel strategy for the detection and definition of HLA-specific antibodies in patients awaiting renal transplantation

  1998cited by this paper
• Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome.

  1998cited by this paper
• Simultaneous HLA Class I and Class II antibodies screening with flow cytometry.

  1998cited by this paper
• Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay

  1997cited by this paper
• The presence of posttransplant HLA-specific IgG antibodies detected by enzyme-linked immunosorbent assay correlates with specific rejection pathologies.

  1997cited by this paper
• Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients.

  1997cited by this paper
• Epitope specificity of HLA class I alloantibodies: II. Stability of cross-reactive group antibody patterns over extended time periods.

  1997cited by this paper
• Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation.

  1996cited by this paper
• Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection.

  1996cited by this paper
• Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines.

  1996cited by this paper
• Five-year results of renal transplantation in highly sensitized recipients

  1996cited by this paper
• Anticipation of highly sensitised renal patients' immunoadsorption requirements by prescreening using protein A minicolumns

  1996cited by this paper
• P256 - Comparison of an ELISA crossmatch (cross-stat) with the NIH and anti-human globulin lymphocytotoxicity assays

  1996cited by this paper
• The use of magnetic beads coated with soluble HLA class I or class II proteins in antibody screening and for specificity determinations of donor-reactive antibodies.

  1996cited by this paper
• Importance of minimizing HLA-DR mismatch and cold preservation time in cadaveric renal transplantation.

  1996cited by this paper
• Successful renal transplantation with a positive T-cell cross match caused by IgM antibodies.

  1995cited by this paper
• Successful kidney transplantation of immunized patients after desensitization with normal human polyclonal immunoglobulins.

  1995cited by this paper
• Renal transplantation to sensitized patients: decreased graft survival probability associated with a positive historical crossmatch.

  1995cited by this paper
• Soluble HLA antigens and ELISA--a new technology for crossmatch testing.

  1995cited by this paper
• A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups.

  1995cited by this paper
• VARIATIONS OF THE LYMPHOCYTOTOXICITY TEST AN EVALUATION OF SENSITIVITY AND SPECIFICITY

  1995cited by this paper
• Successful renal transplantation in the presence of donor specific HLA IgM antibodies.

  1995cited by this paper
• IgG antibodies against an HLA antigen are associated with activated cytotoxic T cells against this antigen, IgM are not.

  1994cited by this paper
• The impact of HLA mismatches on the survival of first cadaveric kidney transplants.

  1994cited by this paper
• IDENTIFICATION OF PATIENTS AT RISK FOR INFERIOR RENAL ALLOGRAFT OUTCOME BY A STRONGLY POSITIVE B CELL FLOW CYTOMETRY CROSSMATCH1

  1994cited by this paper
• Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.

  1994cited by this paper
• The association between a positive T and B cell flow cytometry crossmatch and renal transplant failure.

  1993cited by this paper
• DIFFERENTIAL INHIBITION OF PRIMED ALLOREACTIVE CTLs IN VITRO BY CLINICALLY USED CONCENTRATIONS OF CYCLOSPORINE AND FK506

  1993cited by this paper
• Permissible mismatches, acceptable mismatches, and tolerance: new trends in decision making.

  1993cited by this paper
• Anti-idiotypic antibodies specific for HLA in heart and kidney allograft recipients

  1993cited by this paper
• SIX‐ANTIGEN‐MATCHED TRANSPLANTS: CAUSES OF FAILURE

  1993cited by this paper
• ENZYME‐LINKED IMMUNOASSAY FOR ANTI‐HLA ANTIBODIES—AN ALTERNATIVE TO PANEL STUDIES BY LYMPHOCYTOTOXICITY

  1993cited by this paper
• Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team.

  1993cited by this paper
• A highly sensitive, rapid screening method for the detection of antibodies directed against HLA class I and II antigens

  1993cited by this paper
• SPECIFICITY AND Ig CLASS OF PREFORMED ALLOANTIBODIES CAUSING A POSITIVE CROSSMATCH IN RENAL TRANSPLANTATION: THE IMPLICATIONS FOR GRAFT SURVIVAL

  1993cited by this paper
• POSITIVE CROSSMATCHES AGAINST MANDATORILY SHARED KIDNEYS

  1992cited by this paper
• Current status of HLA matching in renal transplantation

  1992cited by this paper
• Immunoadsorption of anti-HLA antibodies for highly sensitized patients awaiting renal transplantation.

  1992cited by this paper
• Lack of correlation between IgG T‐lymphocyte flow cytometric crossmatches with primary renal allograft outcome

  1992cited by this paper
• THE OCCURRENCE OF CYTOTOXIC AND NON‐COMPLEMENT‐FIXING ANTIBODIES IN THE CROSSMATCH SERUM OF PATIENTS WITH EARLY ACUTE REJECTION EPISODES

  1992cited by this paper
• Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen.

  1992cited by this paper
• Hyperacute and acute kidney graft rejection due to antibodies against B cells.

  1992cited by this paper
• Relevance of positive crossmatches in renal transplantation.

  1992cited by this paper
• Flow cytometry PRA, a new test that is highly correlated with graft survival

  1992cited by this paper
• Collaborative Transplant Study Kidney Exchange Trial for highly sensitized recipients.

  1991cited by this paper
• Production and characterization of human monoclonal lymphocytotoxic autoantibodies from a renal dialysis patient.

  1991cited by this paper
• Influence of antiidiotypic antibody activity on renal transplant outcome.

  1991cited by this paper
• The blood transfusion effect: clinical aspects.

  1991cited by this paper
• The importance of serum dithiothreitol treatment in crossmatching selection of presensitized kidney transplant recipients.

  1990cited by this paper
• The prospective value of the preoperative flow cytometric crossmatch assay in renal transplantation.

  1990cited by this paper
• MULTISCREEN SERUM ANALYSIS OF HIGHLY SENSITIZED RENAL DIALYSIS PATIENTS FOR ANTIBODIES TOWARD PUBLIC AND PRIVATE CLASS I HLA DETERMINANTS: IMPLICATIONS FOR COMPUTER‐PREDICTED ACCEPTABLE AND UNACCEPTABLE DONOR MISMATCHES IN KIDNEY TRANSPLANTATION

  1990cited by this paper
• EFFECT OF PROTEIN A IMMUNOADSORPTION ON PANEL LYMPHOCYTE REACTIVITY IN HYPERIMMUNIZED PATIENTS AWAITING A KIDNEY GRAFT

  1990cited by this paper
• Laboratory and clinical management of the highly sensitized organ transplant recipient.

  1989cited by this paper
• Hyperimmunized patients do not need to wait for an HLA identical donor.

  1989cited by this paper
• THE DEVELOPMENT AND SPECIFICITY OF ANTIIDIOTYPIC ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS RECEIVING SINGLE‐DONOR BLOOD TRANSFUSIONS

  1989cited by this paper
• Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches.

  1989cited by this paper
• Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome.

  1989cited by this paper
• ASSOCIATION OF ANTIIDIOTYPIC ANTIBODY WITH SUCCESSFUL SECOND TRANSPLANT OF A KIDNEY SHARING HLA ANTIGENS WITH THE PREVIOUS HYPERACUTELY REJECTED FIRST KIDNEY

  1989cited by this paper
• Comparison of dithiothreitol (DTT) treatment and absorption using autologous EBV-transformed lymphoblastoid cell lines for the depletion of autoreactive antibodies.

  1989cited by this paper
• The effect of historical crossmatches and sensitization of renal allograft survival.

  1989cited by this paper
• THE RELATIONSHIP BETWEEN FLOW CYTOMETER CROSSMATCH RESULTS AND SUBSEQUENT REJECTION EPISODES IN CADAVER RENAL ALLOGRAFT RECIPIENTS

  1988cited by this paper
• Importance of HLA-A, -B and -DR matching in presensitized kidney transplant recipients.

  1988cited by this paper
• Effect of factors inhibiting HLA-DR antibodies before transplantation on kidney graft survival.

  1988cited by this paper
• RECURRENT HEMOLYTIC UREMIC SYNDROME IN A RENAL TRANSPLANT RECIPIENT AND REVIEW OF THE LEIDEN EXPERIENCE

  1988cited by this paper
• FAILURE TO DECREASE ANTIBODY LEVELS IN SENSITIZED PATIENTS BY REPEATED TRANSFUSIONS FROM ONE DONOR AND CYCLOSPORINE

  1988cited by this paper
• Extracorporeal immunoadsorption of anti-HLA antibodies: preliminary clinical experience.

  1987cited by this paper
• Desensitization--which renal allograft recipients are suitable?

  1987cited by this paper
• Transplant outcome of desensitized recipients after donor-specific transfusion.

  1987cited by this paper
• THE EVALUATION AND RELEVANCE OF AUTOLYMPHOCYTOTOXIC ANTIBODY IN THE HIGHLY PRESENSITIZED PATIENT

  1987cited by this paper
• Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients.

  1987cited by this paper
• Anti-idiotypic autoantibodies after donor-specific blood transfusions.

  1987cited by this paper
• Search for anti-idiotypic antibodies in sera of renal transplant recipients.

  1987cited by this paper
• Reduction of anti-HLA antibody using small-dose single-donor blood transfusion.

  1987cited by this paper
• Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities.

  1987cited by this paper
• Plasma exchange and immunosuppressive therapy before renal transplantation in allosensitized patients.

  1987cited by this paper
• IMMUNOGLOBULIN CLASS AND SPECIFICITY OF ANTIBODIES CAUSING POSITIVE T CELL CROSSMATCHES: RELATIONSHIP TO RENAL TRANSPLANT OUTCOME

  1986cited by this paper
• Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody.

  1986cited by this paper
• SUCCESSFUL CADAVER KIDNEY TRANSPLANTATION IN PATIENTS HIGHLY SENSITIZED BY BLOOD TRANSFUSIONS

  1985cited by this paper
• Outcome of renal transplantation following a positive cross-match with historical sera: the ASHI survey.

  1985cited by this paper
• Positive T cell crossmatch with stored recipient sera in cadaveric renal transplantation.

  1985cited by this paper
• SUCCESSFUL TRANSPLANTATION OF CYCLOSPORINE‐TREATED ALLOGRAFT RECIPIENTS WITH SEROLOGICALLY POSITIVE HISTORICAL, BUT NEGATIVE PREOPERATIVE, DONOR CROSSMATCHES

  1985cited by this paper
• Successful kidney transplantation with current-sera-negative/historical-sera-positive T cell crossmatch.

  1984cited by this paper
• PRETRANSPLANT WARM B CELL ANTIBODIES IN RECIPIENTS OF PRIMARY AND RETRANSPLANTED CADAVER RENAL ALLOGRAFTS

  1984cited by this paper
• Successful removal and prevention of resynthesis of anti-HLA antibody.

  1984cited by this paper
• THE LYMPHOCYTOTOXIC CROSSMATCH TEST IN CLINICAL RENAL TRANSPLANTATION

  1983cited by this paper
• Flow cytometry analysis: A high technology cross-match technique facilitating transplantation

  1983cited by this paper
• Successful renal transplantation despite warm B cell antibodies.

  1983cited by this paper
• Successful renal transplantation in patients with T-cell reactivity to donor.

  1982cited by this paper
• Hyperacute rejection of HLA-AB-identical renal allografts associated with B lymphocyte and endothelial reactive antibodies.

  1982cited by this paper
• Renal allograft rejection associated with presensitization to HLA-DR antigens.

  1981cited by this paper
• Positive crossmatch transplants--safe or not?

  1981cited by this paper
• DONOR‐SPECIFIC B AND T LYMPHOCYTE ANTIBODIES AND KIDNEY GRAFT SURVIVAL

  1981cited by this paper
• Immediate rejection of a HLA-A, B compatible, HLA-DR incompatible kidney with a positive donor-recipient B-cell crossmatch.

  1980cited by this paper
• B cell antibodies and crossmatching.

  1980cited by this paper
• Most positive B cell crossmatches are not caused by anti-HLA-DR antibodies.

  1980cited by this paper
• Retrospective tests of B-cold lymphocytotoxins and transplant survival at a single center.

  1979cited by this paper
• Preexistent anti-HLA-DR antibodies and kidney graft survival.

  1979cited by this paper
• B-cell antibodies and clinical kidney transplantation.

  1978cited by this paper

• Impact of pretransplant anti-HLA antibodies on outcomes in lung transplant candidates.

  2014cites this paper
• Clinical Relevance of Pre-transplant HLA Donor Specific Antibodies (DSA) in Renal Patients waiting for a Transplant: A Risk Factor

  2009cites this paper
• Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor.

  2009cites this paper
• Survival in allosensitized children after listing for cardiac transplantation.

  2007cites this paper
• Comparison of survival in primary and repeat heart transplantation from 1987 through 2004 in the United States.

  2007cites this paper
• Utility of HLAMatchmaker and Single-Antigen HLA-Antibody Detection Beads for Identification of Acceptable Mismatches in Highly Sensitized Patients Awaiting Kidney Transplantation

  2006cites this paper
• Die Entdeckung des kapillären C4d in Nierentransplantaten und die "Renaissance" der humoralen Abstoßung

  2006cites this paper
• Role of Flow Cytometry to Define Unacceptable HLA Antigens in Lung Transplant Recipients with HLA-Specific Antibodies

  2006cites this paper
• Increased transplant opportunity following improved definition of patient sensitisation

  2005cites this paper
• Effect of posttransplant anti-HLA antibody on outcome of renal transplantation.

  2004cites this paper
• Does exposure to swine leukocyte antigens after pig‐to‐nonhuman primate xenotransplantation provoke antibodies that cross‐react with human leukocyte antigens?

  2004cites this paper
• Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.

  2004cites this paper
• Alloantibody and xenoantibody cross-reactivity in transplantation.

  2004cites this paper
• Complement C4d in Graft Capillaries – the Missing Link in the Recognition of Humoral Alloreactivity

  2003cites this paper
• A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1

  2003cites this paper
• Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression

  2003cites this paper
• Comparison of allogeneic and xenogeneic in vitro T‐cell proliferative responses in sensitized patients awaiting kidney transplantation

  2003cites this paper
• Sensitisation to Swine Leukocyte Antigens in Patients with Broadly Reactive HLA Specific Antibodies

  2002cites this paper
• Activated HLA class I-reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failure1

  2002cites this paper
• Clinical impact of delayed graft function for kidney transplantation

  2001cites this paper
• Effect of cold ischemic time and HLA matching in kidneys coming from "young" and "old" donors: do not leave for tomorrow what you can do tonight.

  2001cites this paper
• Selective omission of the donor cross-match before renal transplantation: efficacy, safety and effects on cold storage time.

  2000cites this paper
• A potential revolution in pretransplant histocompatibility testing: selective omission of the donor crossmatch.

  2000cites this paper
• Anti-HLA antibodies after solid organ transplantation.

  2000cites this paper
• Renal transplantation without a pre-transplant crossmatch.

  2000cites this paper